Last Updated on June 13, 2025 by The Health Master
USFDA approval
Alembic Pharmaceuticals has received final USFDA approval to manufacture and distribute Amlodipine and Atorvastatin Tablets in response to an Abbreviated New Drug Application (ANDA).
The final USFDA approval comes for one of the most in-demand combination drugs, which will work wonders for many with cardiovascular issues, giving them a stable dosage option.
What are Amlodipine and Atorvastatin?
To truly appreciate the power of this new drug, one must assess the significance of Amlodipine and Atorvastatin independently since APIs (active pharmaceutical ingredients) are very complicated, and combining them creates better efficacy only seen through comprehensive therapeutic approaches.
Amlodipine:
A calcium channel blocker used to treat high blood pressure (hypertension) and certain types of chest pain (angina); relaxation of blood vessels leads to greater blood flow and less effort needed by the heart.
Atorvastatin:
This is a statin used to lower “bad” cholesterol (LDL-C) and triglycerides in the blood; it’s known to decrease total cholesterol levels.
Therefore, together, the statins lower bad cholesterol, and the blood pressure medication lowers blood pressure, making it one of the most prescribed drugs for those who simultaneously need it—which is not uncommon for those with preexisting cardiovascular concerns, diabetes, or multiple comorbidities.
USFDA Approval granted
The USFDA approval was granted for the following strengths:
- 2.5 mg/10 mg
- 2.5 mg/20 mg
- 2.5 mg/40 mg
- 5 mg/10 mg
- 5 mg/20 mg
- 5 mg/40 mg
- 5 mg/80 mg
- 10 mg/10 mg
- 10 mg/20 mg
- 10 mg/40 mg
- 10 mg/80 mg
ANDA approvals
With this approval, Alembic now holds 223 ANDA USFDA approvals to date; 199 are final and 24 are tentative.
Q: What’s the difference between a brand-name drug and a generic drug?
A: The brand-name drug is the drug originally designed by the licensed designer/manufacturer with patents protecting it from being imitated. The generic drug has the same active ingredients, is bioequivalent, and has the same therapeutic results as branded counterparts; however, the generic is marketed at a reduced price after patent expiration.
Q: Are generic drugs safe and effective?
A: Yes, the FDA approves all generics as either safe or effective compared to branded drugs. According to the FDA, generic drugs must demonstrate bioequivalence, meaning they deliver the identical amount of active ingredient to the bloodstream in the same time and manner as their branded counterparts.
Disclaimer: This article contains information obtained from the source mentioned below. Our team made changes in the format to rewrite and present the news or article in a unique format.
Disclaimer: The information we have provided is for general knowledge and for informational purpose only and it cannot be treated as medical advice. Always consult your doctor for any health issues and / or for the treatment of the same. The Health Master does not claim responsibility for this information.
USFDA approval granted for Raltegravir Tablets
USFDA approval granted for generic Hypertension drug
USFDA approval granted for Rivaroxaban tablets
Tentative USFDA approval granted for Amifampridine Tablets
USFDA approval granted for Methenamine Hippurate Tablets: Zydus
USFDA issues warning on Allergy medicines
FSSAI: Food Labelling and Display – Chapter-18
42 Companies banned over supply of NSQ drugs: Rajasthan
83,090 Tablets of Alprazolam and Zolpidem Seized, 1 Arrested
High Salicylic Acid: India Halts Cosmetic Imports
Drug alert: 196 drug samples declared as NSQ in April 2025
Key Notes on Revised Schedule M: API Part-5
Bengaluru Gears Up for the 74th IPC 2025 with a Focus on AI & Innovation
USFDA inspection: At Reddy’s at New York API plant with 2 observations
